Advanced Medical Iso (ADMD) 0.0061 $ADMD Advanced

New Post Public Reply Private Reply Replies (0) Message Board

Jun 5, 2016 at 2:01 PM

Advanced Medical Iso (ADMD) 0.0061 $ADMD

Advanced Medical Isotope Corporation to Present at the LD Micro Invitational
ACCESSWIRE - Fri Jun 03, 6:22AM CDT
LOS ANGELES, CA / ACCESSWIRE / June 3, 2016 / Advanced Medical Isotope Corporation (or "AMI"

(OTC: ADMD), a late stage development company engaged in the development of brachytherapy devices for therapeutic applications today announced that it will be presenting at the 6th annual LD Micro Invitational on Tuesday, June 7th at 12:30pm. James C. Katzaroff, Founder, CEO and Chairman will be giving the presentation and meeting with investors.

Advanced Medical Isotope Corporation Announces Participation in Upcoming Investment Conferences
ACCESSWIRE - Fri May 27, 9:33AM CDT
KENNEWICK, WA / ACCESSWIRE / May 27, 2016 / Advanced Medical Isotope Corporation (or "AMI"

(OTC: ADMD), a late stage development company engaged in the development of brachytherapy devices for therapeutic applications today announced that it will be presenting at two upcoming investor conferences. The first is the 5th Annual SeeThruEquity Microcap Investor Conference at Convene on 730 Third Avenue in New York City on May 31, 2016. The second is the 6th annual LD Micro Invitational on June 7th in Los Angeles.

Small Healthcare Companies Sometimes Forgotten
PR Newswire - Fri May 27, 9:10AM CDT
The healthcare sector is large and diverse, with biotechs, drug manufacturers, health insurance companies all falling under its umbrella. A rather overlooked sector are the very small healthcare companies. While not often talked about, these healthcare companies are still trying to prove themselves. The United States is by far the largest consumer of the healthcare market in the world. Advanced Medical Isotope Corp. (OTC: ADMD), Nutranomics Inc. (OTC: NNRX), KollagenX Corp. (OTCQB: KGNX), Bioelectronics Corp (OTC: BIEL)

Advanced Medical Isotope Corporation to Present at the 5th Annual SeeThruEquity Microcap Investor Conference in New York City on May 31, 2016
ACCESSWIRE - Thu May 26, 6:22AM CDT
KENNEWICK, WA / ACCESSWIRE / May 26, 2016 / Advanced Medical Isotope Corporation (or "AMI"

(OTC: ADMD), a late stage development company engaged in the development of brachytherapy devices for therapeutic applications, today announced that the company will present at the 5th Annual SeeThruEquity Microcap Investor Conference at Convene on 730 Third Avenue in New York City on May 31, 2016. Please click here for a list of presenting companies.

Dr. Albert S. DeNittis and Advanced Medical Isotope Founder CEO and Chairman, James C. Katzaroff, are Featured in a New Audio Interview at SmallCapVoice.com
GlobeNewswire - Wed Apr 27, 6:22AM CDT
SmallCapVoice.com, Inc. (SCV) and Advanced Medical Isotope Corporation (or "AMI"

(OTC:ADMD), (www.IsotopeWorld.com) a late stage development company engaged in the development of brachytherapy devices for therapeutic applications, announced today that a new audio interview with the Company is now available. The interview can be heard at http://smallcapvoice.com/blog/4-26-16-smallca...ation-admd

Advanced Medical Isotope Announces FDA Resubmission Progress; Stands Ready to Ship First Batch of RadioGel(TM) for Veterinary Division
ACCESSWIRE - Fri Apr 22, 9:11AM CDT
KENNEWICK, WA/ ACCESSWIRE / April 22, 2016 / Advanced Medical Isotope Corporation (or "AMI"

(OTC: ADMD), a late stage development company engaged in the development of brachytherapy devices for therapeutic applications provides a progress update on product development, manufacturing and commercialization efforts.

StockNewsNow.com Publishes New SNNLive Video Interview With Advanced Medical Isotope Corporation
Marketwired - Mon Apr 18, 7:39AM CDT
StockNewsNow.com, The Official MicroCap News Source(TM), today published an SNNLive Video Interview with James C. Katzaroff, Chairman and CEO of Advanced Medical Isotope Corporation (OTC PINK: ADMD), a late stage radiation oncology focused medical device company engaged in the development of yttrium-90 based brachytherapy devices for the treatment of non-resectable tumors, according to the Company's website (see here: www.IsotopeWorld.com). The video interview was recorded on Monday, February 22nd, 2016, at the SeeThruEquity & The Brewer Group's 2nd Annual Innovations Investor Conference 2016 in Miami, FL.

Trading Penny Stock: Four Small Cap Equities Actively Traded on Wednesday April 13
ACCESSWIRE - Wed Apr 13, 12:11PM CDT
MIAMI, FL / ACCESSWIRE / April 13, 2016 / Daily Stock Reporter is issuing a report on four stocks to watch. NECA, ADMD, TRTC, and FFMGF have been added to our watch list today. Continue reading to find out why. - To get daily alerts on top stocks on the OTC, Nasdaq and NYSE subscribe to our newsletter at DailyStockReporter.com.

A New Audio Interview with Advanced Medical Isotope is now at SmallCapVoice.com
GlobeNewswire - Tue Apr 12, 6:22AM CDT
SmallCapVoice.com, Inc. (SCV) and Advanced Medical Isotope Corporation (or "AMI"

(OTC:ADMD), (www.IsotopeWorld.com) a late stage development company engaged in the development of brachytherapy devices for therapeutic applications, announced today that a new audio interview with the Company is now available. The interview can be heard at http://smallcapvoice.com/blog/4-11-16-smallca...ation-admd.

The Last Time This Company Made A FDA Submission It Ran 2,100%-- Here's Why You Should Be Looking At It Right Now
ACCESSWIRE - Wed Mar 30, 6:00AM CDT
WINDSOR, ON / ACCESSWIRE / March 30, 2016 / The Wealthy Biotech Trader (or "WBT"

, an investment newsletter focused on showing everyday investors new opportunities in rapidly growing, little-known, biotech, pharma and medical device stocks making news and subsequent market moves, would like to highlight that the maximum gains are made by investors who seek out promising pharma companies before their filing of FDA approval.
AGEN: 4.38 (-0.12), ARGS: 6.21 (+0.02)

SeeThruEquity Initiates Coverage on Advanced Medical Isotope Corporation (OTC: ADMD) with a Target Price of $0.02
ACCESSWIRE - Tue Mar 22, 6:23AM CDT
NEW YORK, NY / ACCESSWIRE / March 22, 2016 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has initiated coverage on Advanced Medical Isotope Corporation (OTC: ADMD) with a target price of $0.02.

Meet the Biotech Company About to Turn the 120-Year-Old Cancer Radiation Industry on Its Head
ACCESSWIRE - Fri Mar 18, 1:49PM CDT
WINDSOR, ON / ACCESSWIRE / March 18, 2016 / The Wealthy Biotech Trader (or "WBT"

, an investment newsletter focused on showing everyday investors new opportunities in rapidly growing, little-known, biotech, pharma and medical device stocks making news and subsequent market moves, would like to highlight a new stock pick, Advanced Medical Isotope (OTC: ADMD), which WBT believes has the ability to cause a massive paradigm shift in the cancer treatment space, and potentially capture a large segment of the burgeoning internal radiation therapy market. We look to follow this company as they expect to make another FDA submission later this year, which should catapult the stock if they receive the anticipated marketing clearance. We also contrast and compare a few other companies in the industry.
ATNM: 1.81 (-0.09), ISR: 0.86 (-0.05), ARAY: 5.54 (-0.09)

Advanced Medical Isotope Corporation Launches IsoPet Solutions to Focus on the Veterinary Market
ACCESSWIRE - Tue Mar 15, 6:22AM CDT
KENNEWICK, WA / ACCESSWIRE / March 15, 2016 / Advanced Medical Isotope Corporation (or "AMI"

(OTC: ADMD), (www.IsotopeWorld.com) a late stage development company engaged in the development of brachytherapy devices for therapeutic applications announced the formation of a new, wholly-owned subsidiary, IsoPet Solutions Corporation, to focus on the vibrant and expanding veterinary oncology market.

Advanced Medical Isotope Corporation Appoints Dr. Alice Villalobos Chair of the Veterinary Medicine Advisory Board
ACCESSWIRE - Mon Mar 14, 6:22AM CDT
KENNEWICK, WA / ACCESSWIRE / March 14, 2016 / Advanced Medical Isotope Corporation (or "AMI"

(OTC: ADMD), a late stage development company engaged in the development of brachytherapy devices for therapeutic applications, today announced that Dr. Alice Villalobos, DVM, FNAP, a specialist and advocate on the topic of cancer in pets, has been appointed Chair of the Company's Veterinary Medicine Advisory Board.

Advanced Medical Isotope Corporation Retains Circadian Group to Launch Long-Term Comprehensive Investor Relations Program
BusinessWire - Wed Jan 20, 6:22AM CST
Advanced Medical Isotope Corporation ("AMIC"

(OTC: ADMD), a late stage development company engaged in the development of brachytherapy devices for therapeutic applications, today announced the retention of world-class Investor Relations firm Circadian Group, an online-focused leader in shareholder development and engagement, with a proven track record in the medical device, pharmaceutical and biotech industries.

Advanced Medical Isotope Corporation Reports Progress Towards Seeking FDA Clearance for the Y-90 RadioGel(TM) Device
BusinessWire - Tue Nov 17, 3:22AM CST
Advanced Medical Isotope Corporation ("AMIC"

(OTC: ADMD), a late stage development company engaged in the development of brachytherapy devices for therapeutic applications, today announced its progress in seeking FDA clearance for marketing of its lead product, the Y-90 RadioGel(TM) device.

Advanced Medical Isotope Corporation Completes Substantial Capital Restructuring Activities and Continues Product Development
BusinessWire - Wed Oct 07, 2:25PM CDT
Advanced Medical Isotope Corporation ("AMIC"

(OTC Pink:ADMD), a late stage development company engaged in the development of brachytherapy devices for therapeutic applications, today provided the following financial and regulatory update.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cracking Down on Insider Trading: Legal vs Illegal

Why the Insider Trading Line Isn't Always Clear-Cut Insider trading is one of those buzzwords that conjures up images of Wall Street shenanigans and pricey legal battles. But believe it or not, trading on insider info isn’t always a one-way ticket to a federal prison. What determines its legality often hinges on how the information was obtained and used. It's a...

Mixed Wage Growth: Gains for Some, Challenges Persist

A Closer Look at Q3 Earnings I tell you, these numbers from the Ludwig Institute make for a pretty mixed bag. Sure, we got a slight nudge upwards in those median weekly earnings for the third quarter, like from $1,035 to $1,041. It’s a pinch of positive news, but hang on a sec before you start celebrating. The reality ain't shifting for a lot of folks, especially if...

Gillis Joins McGinnis Lochridge as COO Amid Firm's Milestone

An Experienced Executor at the Helm Now, here's a story that rings of continuity meeting change. McGinnis Lochridge, a staple of the Texas legal scene since 1927, has tapped Charles Gillis to take charge as their Chief Operating Officer. You'd think they're gearing up to celebrate a hundred years by shaking things up internally. Why not bring in someone seasoned, I say?...

Omio Reveals Top 6 Trends Shaping 2026-2027 Travel

Decoding the Changing Travel Landscape This ain't your grandparents' travel itinerary. The 2026-2027 travel season is already shaping up to be a wild reimagining of what it means to 'get away.' Omio's latest NowNext Travel Report, crafted alongside YouGov, pulls back the curtain on how folks are recalibrating their vacations in light of financial squeezes and climate...

Labcorp, FDA Collaborate to Tackle Drug Abuse Risks

Rethinking How We Evaluate Drug Abuse Potential Sometimes, the finance world gets a peek into something that ain't just about the numbers on a screen, something with real stakes beyond the bulls and bears. Labcorp's just thrown its hat in with the FDA and Charles River Laboratories in a collaboration that goes beyond just lining pockets. They're setting up to dissect how...

CTG Data Breach Sparks Class Action Investigation

CTG Faces Scrutiny Over Recent Data Breach Ah, the thrills and spills of the digital age—yet another company stumbling headfirst into a data breach mess. This time, it’s Computer Task Group (CTG) taking center stage, with its IT systems compromised and personal info slipping through the cracks. On September 26, 2026, an unwelcome guest rooted around their network,...

Procede Software Acquires RIMSS: Dealer Tech Shift?

Procede's Big Play Seems like Procede Software is tossing the dice with its latest move. The software scene for dealership management is as cutthroat as a New York deli lineup, and now we've got Procede moving to scoop up RIMSS. This isn't just a back-office shuffle; it's a world-rocking maneuver that brings decades of dealer technology know-how into one basket. What's...

Asia-Pacific Travel Boom Spurs Growth in Emerging Cities

The Rise of Emerging Destinations in Asia-Pacific You could say the kids are driving the show this autumn, with Gen Z leading the charge in the Asia-Pacific travel boom. A surge in bookings across emerging destinations is shaking things up, and the scene feels fresh as a cold autumn breeze. We're seeing some stunning numbers—Chiang Mai up by a whopping 84.3%, followed...

Clarivate Taps Global Appetite for AI Research Tools

A Growing Global Thirst for AI-Enhanced Research It looks like the folks at Clarivate have struck a chord. Their Web of Science Research Intelligence platform is garnering attention across the globe, embraced by more than 100 institutions spanning 25 countries. When you craft something that taps into a core need, well, people will jump on it—and that's exactly what's...

S&T Bancorp Hits Record Highs in Q3 2026

Surpassing Expectations with Record Metrics Well, if it isn’t another stellar quarter for S&T Bancorp (NASDAQ:STBA). The folks over in Indiana, PA, just threw down some serious numbers. The third quarter of 2026 saw net income climbing to $38.6 million, up from $36.6 million last quarter. That's a decent hike if you ask me. But what really stole the spotlight here was...